NMPA Approval

Trimetazidine Dihydrochloride Sustained-release Tablets

Approval Number

国药准字H20243573

Company瑞阳制药股份有限公司

Registration Date

April 24, 2024

Drug Information

Generic Name

盐酸曲美他嗪缓释片

Dosage Form

片剂

Strength

35mg

Drug Type

化学药品

Registration Date

April 24, 2024

Company Information

Applicant Company

Company Name瑞阳制药股份有限公司

Company Address

山东省沂源县城瑞阳路1号

Manufacturing Company

Company Name瑞阳制药股份有限公司

Company Address

山东省沂源县城瑞阳路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸曲美他嗪缓释片 - NMPA 批准文号 | MedPath